Protection against oxidative stress-induced neurodegeneration by a modulator for DJ-1, the wild-type of familial parkinson's disease-linked PARK7

Journal of Pharmacological Sciences

Volumn 109, Issue 3, 2009, Pages 463-468

  Yanagida, Takashi ^a   Kitamura, Yoshihisa ^a   Yamane, Koichiro ^a   Takahashi, Kazunori ^b   Takata, Kazuyuki ^a   Yanagisawa, Daijiro ^a   Yasui, Hiroyuki ^a   Taniguchi, Takashi ^a   Taira, Takahiro ^c   Honda, Toshio ^b   Ariga, Hiroyoshi ^d  

^a KYOTO PHARMACEUTICAL UNIVERSITY   (Japan)

^b HOSHI UNIVERSITY   (Japan)

^c UNIVERSITY OF YAMANASHI   (Japan)

^d HOKKAIDO UNIVERSITY   (Japan)

Author keywords

Anti oxidative effect; DJ 1 modulator; Neuroprotection

Indexed keywords

2 [3 (BENZYLOXY) 4 METHOXYPHENYL] N [2 (7 METHOXY 1,3 BENZODIOXOL 5 YL)ETHYL]ACETAMIDE; DJ 1 PROTEIN; HYDROGEN PEROXIDE; NEUROPROTECTIVE AGENT; REACTIVE OXYGEN METABOLITE; UCP 0054278; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN ISCHEMIA; CELL DEATH; CELL SURVIVAL; CONTROLLED STUDY; DRUG EFFECT; DRUG PROTEIN BINDING; DRUG STRUCTURE; HUMAN; HUMAN CELL; MALE; NERVE DEGENERATION; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; RAT; WILD TYPE;

ANIMALS; BENZAMIDES; BENZODIOXOLES; BRAIN ISCHEMIA; CELL DEATH; CELL LINE, TUMOR; DISEASE MODELS, ANIMAL; HUMANS; HYDROGEN PEROXIDE; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; NERVE DEGENERATION; NEUROBLASTOMA; NEUROPROTECTIVE AGENTS; ONCOGENE PROTEINS; OXIDATIVE STRESS; PARKINSON DISEASE; RATS; RATS, WISTAR; REACTIVE OXYGEN SPECIES;

EID: 67249120091     PISSN: 13478613     EISSN: 13478648     Source Type: Journal    
DOI: 10.1254/jphs.08323SC     Document Type: Article

References (16)

1. Nagakubo D, Taira T, Kitaura H, Ikeda M, Tamai K, Iguchi- Ariga SM, et al. DJ-1, a novel oncogene which transforms mouse NIH3T3 cells in cooperation with ras. Biochem Biophys Res Commun. 1997;31:509-513.
2. Bonifati V, Rizzu P, van Baren MJ, Schaap O, Breedveld GJ, Krieger E, et al. Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism. Science. 2003; 299:256-259. (Pubitemid 36131051)
3. Taira T, Saito Y, Niki T, Iguchi-Ariga SM, Takahashi K, Ariga H. DJ-1 has a role in antioxidative stress to prevent cell death. EMBO Rep. 2004;5:213-218. (Pubitemid 38401204)
4. Inden M, Taira T, Kitamura Y, Yanagida T, Tsuchiya D, Takata K, et al. PARK7 DJ-1 protects against degeneration of nigral dopaminergic neurons in Parkinson's disease rat model. Neuro- biol Dis. 2006;24:144-158. (Pubitemid 44416214)
5. Yanagida T, Takata K, Inden M, Kitamura Y, Taniguchi T, Yoshimoto K, et al. Distribution of DJ-1, Parkinson's disease- related protein PARK7, and its alteration in 6-hydroxy- dopamine-treated hemiparkinsonian rat brain. J Pharmacol Sci. 2006;102:243-247.
6. Yanagisawa D, Kitamura Y, Inden M, Takata K, Taniguchi T, Morikawa S, et al. DJ-1 protects against neurodegeneration caused by focal cerebral ischemia and reperfusion in rats. J Cereb Blood Flow Metab. 2008;28:563-578.
7. Kinumi T, Kimata J, Taira T, Ariga H, Niki E. Cysteine-106 of DJ-1 is the most sensitive cysteine residue to hydrogen peroxide- mediated oxidation in vivo in human umbilical vein endothelial cells. Biochem Biophys Res Commun. 2004;317:722-728. (Pubitemid 38481432)
8. Miyazaki S, Yanagida T, Nunome K, Ishikawa S, Inden M, Kitamura Y, et al. DJ-1-binding compounds prevent oxidative stress-induced cell death and movement defect in Parkinson's disease model rats. J Neurochem. 2008;105:2418-2434.
9. Yanagida T, Takeuchi H, Kitamura Y, Takata K, Minamino H, Shibaike T, et al. Synergistic effect of galantamine on nicotine- induced neuroprotection in hemiparkinsonian rat model. Neurosci Res. 2008;62:254-261.
10. Zhou W, Zhu M, Wilson MA, Petsko GA, Fink AL. The oxidation state of DJ-1 regulates its chaperone activity toward alpha-synuclein. J Mol Biol. 2006;356:1036-1048. (Pubitemid 43145955)
11. Allard L, Burkhard PR, Lescuyer P, Burgess JA, Walter N, Hochstrasser DF, et al. PARK7 and nucleoside diphosphate kinase A as plasma markers for the early diagnosis of stroke. Clin Chem. 2005;51:2043-2051. (Pubitemid 41532619)
12. Waragai M, Wei J, Fujita M, Nakai M, Ho G, Masliah E, et al. Increased level of DJ-1 in the cerebrospinal fluids of sporadic Parkinson's disease. Biochem Biophys Res Commun. 2006;345:967-972. (Pubitemid 43776502)
13. Clements CM, McNally RS, Conti BJ, Mak TW, Ting JP. DJ-1, a cancer-and Parkinson's disease-associated protein, stabilizes the antioxidant transcriptional master regulator Nrf2. Proc Natl Acad Sci USA. 2006;103:15091-15096. (Pubitemid 44583169)
14. Xu J, Zhong N, Wang H, Elias JE, Kim CY, Woldman I, et al. The Parkinson's disease-associated DJ-1 protein is a transcrip- tional co-activator that protects against neuronal apoptosis. Hum Mol Genet. 2005;14:1231-1241. (Pubitemid 40613911)
15. Junn E, Taniguchi H, Jeong BS, Zhao X, Ichijo H, Mouradian MM. Interaction of DJ-1 with Daxx inhibits apoptosis signal- regulating kinase 1 activity and cell death. Proc Natl Acad Sci USA. 2005;102:9691-9696. (Pubitemid 40981742)
16. Sekito A, Koide-Yoshida S, Niki T, Taira T, Iguchi-Ariga SM, Ariga H. DJ-1 interacts with HIPK1 and affects H2O2-induced cell death. Free Radic Res. 2006;40:155-165. (Pubitemid 43050878)